Strategic Research Institute, Loews Coronado Bay Resort
August 2-3, 2004
This conference is about the deals that are surging in the Bio-Pacific region, led by Japan, as both US companies and their Japanese counterparts more actively than ever seek compounds, reciprocal market access and other strategic partnerships. We have assembled a stellar line-up from US and Japanese Pharma and other firms to foster excellent information exchange and even better networking. The emerging Chinese biotech industry is featured prominently, too, as its potential for pharmaceutical greatness is finally beginning to be realized. The comprehensive coverage to be presented includes market investment and partnership analyses, discussion of important IP and tax issues, presentations from several biotech companies themselves, and a Pfizer assessment of the Chinese market.
|
|